Changes of splenic macrophage during the process of liver cancer induced by diethylnitrosamine in rats

Chinese Medical Journal

Volumn 122, Issue 24, 2009, Pages 3043-3047

  Zhang, Shu ^a   Li, Zong Fang ^a   Pan, Dun ^a   Huang, Chen ^b   Zhou, Rui ^a   Liu, Zhong Wei ^a  

^a Xii an Jiaotong University   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cell function; Liver cancer; Macrophage; Spleen; Ultrastructure

Indexed keywords

DIETHYLNITROSAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER MODEL; CELL ORGANELLE; CELL SWELLING; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ELECTRON MICROSCOPE; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSPOT ASSAY; LIVER CANCER; LIVER CIRRHOSIS; LUNG METASTASIS; LYSOSOME; MACROPHAGE; MALE; MITOCHONDRION; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN SECRETION; PSEUDOPODIUM; RAT; RIBOSOME; SPLEEN; TRANSMISSION ELECTRON MICROSCOPY; TUMOR IMMUNITY; ULTRASTRUCTURE;

ANIMALS; CELLS, CULTURED; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; LIVER CIRRHOSIS; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MACROPHAGES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

EID: 74549198702     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene 2006; 25: 3778-3786.
2. Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 2006; 27: 2070-2082.
3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687.
4. Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, et al. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chin Med J 2007; 120: 703-707.
5. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
6. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38 Suppl 1: S136-S149.
7. Wakeman CJ, Dobbs BR, Frizelle FA, Bissett IP, Dennett ER, Hill AG, et al. The impact of splenectomy on outcome after resection for colorectal cancer: a multicenter, nested, paired cohort study. Dis Colon Rectum 2008; 51: 213-217.
8. Renukaradhya GJ, Khan MA, Vieira M, Du W, Gervay-Hague J, Brutkiewicz RR. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 2008; 111: 5637-5645.
9. Blishchenko EY, Sazonova OV, Yatskin ON, Kalinina OA, Tolmazova AG, Philippova MM, et al. beta-Actin-derived peptides isolated from acidic extract of rat spleen suppress tumor cell growth. J Pept Sci 2008; 14: 811-818.
10. McGory ML, Zingmond DS, Sekeris E, Ko CY. The significance of inadvertent splenectomy during colorectal cancer resection. Arch Surg 2007; 142: 668-674.
11. Jones HP, Wang YC, Aldridge B, Weiss JM. Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. Cancer Immun 2008; 8: 4.
12. Yan F, Li Z, Zhang S, Yang J, Li A, Liu X. Isolation and purification of macrophages from human spleen. J Xi'an Jiaotong Univ (Med Sci) 2004; 25: 513-516.
13. Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol 2006; 34: 455-465.
14. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606-616.
15. Li ZF, Zhang S, Huang Y, Xia XM, Li AM, Pan D, et al. Morphological changes of blood spleen barrier in portal hypertensive spleen. Morphological changes of blood spleen barrier in portal hypertensive spleen. Chin Med J 2008; 121: 561-565.
16. Oflazoglu E, Stone IJ, Gordon KA, Grewal IS, van Rooijen N, Law CL, et al. Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30. Blood 2007; 110: 4370-4372.
17. Foukas LC, Katsoulas HL, Paraskevopoulou N, Metheniti A, Lambropoulou M, Marmaras VJ. Phagocytosis of Escherichia coli by insect hemocytes requires both activation of the Ras/mitogen-activated protein kinase signal transduction pathway for attachment and beta3 integrin for internalization. J Biol Chem 1998; 273: 14813-14818.
18. Wan CP, Park CS, Lau BH. A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods 1993; 162: 1-7.
19. Kim KR, Son EW, Rhee DK, Pyo S. The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro. Toxicol In Vitro 2002; 16: 517-523.
20. Keller R, Keist R, Frei K. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur J Immunol 1990; 20: 695-698.
21. Calzascia T, Pellegrini M, Hall H, Sabbagh L, Ono N, Elford AR, et al. TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J Clin Invest 2007; 117: 3833-3845.
22. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72: 3666-3670.
23. Khalil G, El-Sabban M, Al-Ghadban S, Azzi S, Shamra S, Khalife S, et al. Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin. Eur Cytokine Netw 2008; 19: 131-141.
24. Biglino A, Crivelli P, Concialdi E, Bolla C, Montrucchio G. Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis. Infection 2008; 36: 601-604.
25. Yoon JC, Rehermann B. Determination of HCV-specific T-cell activity. Methods Mol Biol 2009; 510: 403-413.